Paradoxical functions of ZEB1 in EGFR-mutant lung cancer: tumor suppressor and driver of therapeutic resistance

J Thorac Dis. 2016 Nov;8(11):E1528-E1531. doi: 10.21037/jtd.2016.11.59.

Authors

Zachary A Yochum¹, Mark A Socinski², Timothy F Burns¹

Affiliations

¹ Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA, USA;; Department of Medicine, Division of Hematology-Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.
² Florida Hospital Cancer Institute, Orlando, FL, USA.

No abstract available

Publication types

Comment

Grants and funding